Sandra Horning

Dr. Sandra J.
Horning, MD, is an Independent Director at Revolution Medicines, Inc., an Independent Director at Olema Pharmaceuticals, Inc., an Independent Director at Moderna, Inc., an Independent Director at Gilead Sciences, Inc. and a Professor-Emeritus at Stanford University School of Medicine.
She is on the Board of Directors at Revolution Medicines, Inc., Cellarity Inc., Olema Pharmaceuticals, Inc., Moderna, Inc. and Gilead Sciences, Inc. Dr. Horning was previously employed as a Co-Founder by EQRx International, Inc., an Independent Director by EQRx, Inc., a Chief Medical Officer & Head-Product Development by Roche, Inc., an EVP-Global Development by Genentech, Inc., a Chief Medical Officer by Roche Holdings, Inc., and a President by American Society of Clinical Oncology, Inc. She also served on the board at Foundation Medicine, Inc. She received her undergraduate degree from the University of Iowa and a doctorate degree from the University of Iowa.